OncoPT: long-context transformer models for in hospital tumor phenotype extraction from pathology reports
npj Digital Medicine, Published online: 02 May 2026; doi:10.1038/s41746-026-02630-5OncoPT: long-context transformer models for in hospital tumor phenotype extraction from pathology reports
Shared decision making using augmented reality a multicentre pilot randomised controlled trial in orthognathic surgery
npj Digital Medicine, Published online: 02 May 2026; doi:10.1038/s41746-026-02688-1Shared decision making using augmented reality a multicentre pilot randomised controlled trial in orthognathic surgery
Anonymization and visualization of health data and biomarkers
npj Digital Medicine, Published online: 02 May 2026; doi:10.1038/s41746-026-02662-xAnonymization and visualization of health data and biomarkers
Stryker maintains FY26 outlook despite cyberattack-impacted Q1
Stryker was hit by a cyberattack that caused widespread disruption to its operations on 11 March 2026.
The post Stryker maintains FY26 outlook despite cyberattack-impacted Q1 appeared first on Medical Device Network.
Podcast: PET tracers’ role in precision medicine paradigms for neurodegenerative diseases
Swiss biotech AC Immune discusses its PET tracer's potential in realising precision medicine approaches to neurodegenerative diseases.
The post Podcast: PET tracers’ role in precision medicine paradigms for neurodegenerative diseases appeared first on Medical Device Network.
FDA grants breakthrough status to Capitan Orthopedics’ SupraSpacer implant
The FDA has awarded a breakthrough device designation for Capitan Orthopedics' SupraSpacer implant for patients with irreparable rotator cuff tears.
The post FDA grants breakthrough status to Capitan Orthopedics’ SupraSpacer implant appeared first on Medical Device Network.
Dexcom reports 15% YoY revenue uptick in Q1 yet maintains prior FY26 outlook
Dexcom has opted not to raise its FY26 revenue outlook due to the current geopolitical environment.
The post Dexcom reports 15% YoY revenue uptick in Q1 yet maintains prior FY26 outlook appeared first on Medical Device Network.
MintNeuro and Motif Neurotech collaborate for mental health therapies
MintNeuro has signed a partnership with Motif Neurotech to advance the development of miniature BCI therapy for mental health conditions.
The post MintNeuro and Motif Neurotech collaborate for mental health therapies appeared first on Medical Device Network.
Governance for safe and responsible AI in healthcare organisations: a scoping review of frameworks
npj Digital Medicine, Published online: 01 May 2026; doi:10.1038/s41746-026-02679-2Governance for safe and responsible AI in healthcare organisations: a scoping review of frameworks
GE HealthCare’s stock plunges 13% as supply chain costs bite
GE HealthCare has cut its 2026 growth outlook by 3.3% at the top end, citing increasing freight costs for oil and other materials.
The post GE HealthCare’s stock plunges 13% as supply chain costs bite appeared first on Medical Device Network.
Parkinson’s disease: neuromodulation and the search for disease modification
Neuromodulation is an adjunct to medication for Parkinson’s symptom management, with growing interest in whether it could one day contribute to disease-modifying therapies.
The post Parkinson’s disease: neuromodulation and the search for disease modification appeared first on Medical Device Network.
MUSC and Revival Healthcare to advance medical technologies
The MUSC and Revival Healthcare Capital have entered a partnership aimed at advancing the clinical development of medical technologies.
The post MUSC and Revival Healthcare to advance medical technologies appeared first on Medical Device Network.
Axoft raises $55m to advance BCI made of Fleuron
The funds will advance Axoft’s existing clinical trial programmes and progress US regulatory activities for its implantable brain-computer interface.
The post Axoft raises $55m to advance BCI made of Fleuron appeared first on Medical Device Network.
enVVeno Medical secures FDA IDE approval for venous valve study
enVVeno Medical has received the IDE approval from the US FDA for a pivotal study involving a non-surgical replacement venous valve.
The post enVVeno Medical secures FDA IDE approval for venous valve study appeared first on Medical Device Network.
This AI knew the answers but didn’t understand the questions
For decades, psychologists have debated whether the human mind can be explained by one unified theory or must be broken into separate parts like memory and attention. A recent AI model called Centaur seemed to offer a breakthrough, claiming it could mimic human thinking across 160 different cognitive tasks. But new research is challenging that bold claim, suggesting the model isn’t truly “thinking
Deep-learning based quantitative evaluation of postoperative atelectasis following right upper lobectomy
npj Digital Medicine, Published online: 30 April 2026; doi:10.1038/s41746-026-02683-6Deep-learning based quantitative evaluation of postoperative atelectasis following right upper lobectomy
Key concept learning for medical vision language model with reasoning capabilities
npj Digital Medicine, Published online: 30 April 2026; doi:10.1038/s41746-026-02676-5Key concept learning for medical vision language model with reasoning capabilities
Empowering surgeons with integrated synthetic data: solutions for mastering complex clinical scenarios
npj Digital Medicine, Published online: 30 April 2026; doi:10.1038/s41746-026-02660-zEmpowering surgeons with integrated synthetic data: solutions for mastering complex clinical scenarios
Reinforcement learning improves LLM accuracy and reasoning in disease classification from radiology reports
npj Digital Medicine, Published online: 30 April 2026; doi:10.1038/s41746-026-02685-4Reinforcement learning improves LLM accuracy and reasoning in disease classification from radiology reports
A quantitative analysis of global AI medical studies: gaps in randomized controlled trials
npj Digital Medicine, Published online: 30 April 2026; doi:10.1038/s41746-026-02698-zA quantitative analysis of global AI medical studies: gaps in randomized controlled trials